Literature DB >> 16642471

Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma.

Jenny C Ho1, Siu Tim Cheung, Mohini Patil, Xin Chen, Sheung Tat Fan.   

Abstract

Glycosyl-phosphatidylinositol (GPI) anchor attachment protein 1 (GPAA1) transcript level was frequently up-regulated in our earlier study on gene expression profile. We therefore analyzed the potential involvement of GPAA1 in hepatocellular carcinoma (HCC) as GPAA1 gene locates at chromosome 8q24.3 which chromosome region is frequently amplified in HCCs. In this study, we observed that GPAA1 transcript in the HCCs (n = 93) showed a significantly higher expression level compared with their paralleled adjacent nontumor liver tissues, cirrhosis (n = 15) and normal (n = 16) liver tissues using real-time quantitative RT-PCR (p < 0.005). We also demonstrated that GPAA1 protein up-regulation was common in HCCs (90%, 9/10), and GPAA1 gene was frequently amplified (73%, 11/15) using quantitative microsatellite analysis. Increased GPAA1 expression was significantly associated with HCCs poor cellular differentiation (p = 0.011) and poor prognosis (p = 0.010). We then modulated the GPAA1 expression level in HCC cells (Hep3B) by transfection experiments, which was shown to positively regulate cell adhesion ability (p = 0.004) and proliferation rate (p = 0.037). Our data revealed GPAA1 gene amplification with overexpression of RNA and protein in HCC. GPAA1 is a potential amplification target of chromosome 8q and responsible to regulate tumor cells behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642471     DOI: 10.1002/ijc.22005

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Glycosylphosphatidylinositol Anchor Modification Machinery Deficiency Is Responsible for the Formation of Pro-Prion Protein (PrP) in BxPC-3 Protein and Increases Cancer Cell Motility.

Authors:  Liheng Yang; Zhenxing Gao; Lipeng Hu; Guiru Wu; Xiaowen Yang; Lihua Zhang; Ying Zhu; Boon-Seng Wong; Wei Xin; Man-Sun Sy; Chaoyang Li
Journal:  J Biol Chem       Date:  2015-12-18       Impact factor: 5.157

2.  The fatal attraction between pro-prion and filamin A: prion as a marker in human cancers.

Authors:  Man-Sun Sy; Chaoyang Li; Shuiliang Yu; Wei Xin
Journal:  Biomark Med       Date:  2010-06       Impact factor: 2.851

Review 3.  Binding of pro-prion to filamin A: by design or an unfortunate blunder.

Authors:  C Li; W Xin; M-S Sy
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

4.  Down-regulation of retinol binding protein 5 is associated with aggressive tumor features in hepatocellular carcinoma.

Authors:  Jenny C Y Ho; Siu Tim Cheung; Wing Sem Poon; Yuk Ting Lee; Irene O L Ng; Sheung Tat Fan
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-12       Impact factor: 4.553

5.  Profiling the expression pattern of GPI transamidase complex subunits in human cancer.

Authors:  Jatin K Nagpal; Santanu Dasgupta; Sana Jadallah; Young K Chae; Edward A Ratovitski; Antoun Toubaji; George J Netto; Toby Eagle; Aviram Nissan; David Sidransky; Barry Trink
Journal:  Mod Pathol       Date:  2008-05-16       Impact factor: 7.842

6.  Elevated levels of glycosylphosphatidylinositol (GPI) anchored proteins in plasma from human cancers detected by C. septicum alpha toxin.

Authors:  Samuel Dolezal; Shanterian Hester; Pamela S Kirby; Allison Nairn; Michael Pierce; Karen L Abbott
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

7.  Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol-anchored proteins through selective glycan enrichment.

Authors:  Leslie K Cortes; Saulius Vainauskas; Nan Dai; Colleen M McClung; Manesh Shah; Jack S Benner; Ivan R Corrêa; Nathan C VerBerkmoes; Christopher H Taron
Journal:  Proteomics       Date:  2014-11       Impact factor: 3.984

8.  Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun.

Authors:  Dong-Hao Jin; Jeeyun Lee; Kyoung Mee Kim; Sung Kim; Duk-Hwan Kim; Joobae Park
Journal:  Oncotarget       Date:  2015-08-21

9.  Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells.

Authors:  Yan Li; Min Zhu; Yani Huo; Xuerong Zhang; Ming Liao
Journal:  Exp Ther Med       Date:  2018-09-17       Impact factor: 2.447

10.  Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294.

Authors:  Alan Lap-Yin Pang; Alexandra C Title; Owen M Rennert
Journal:  Oncol Lett       Date:  2014-04-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.